Lupus Foundation of America

Lewin contact: Clifford Goodman

The Lupus Foundation of America, Inc. commissioned The Lewin Group  to prepare a report focusing on the multi-dimensional challenges related to the development and approval of new therapies to treat lupus and to develop recommendations for a path forward to address the unmet needs of individuals with lupus. The process for developing this report comprised two parts. The first was conducting a series of interviews with lupus experts across the country to identify the main current barriers to lupus drug development and approval. The second was to
convene and facilitate an expert panel to elicit a broad range of informed opinions on obstacles to lupus drug development and approval and possible approaches for overcoming them.

"Throughout the engagement, Lewin consultants listened to us and delivered superb analyses and thoughtful guidance–not canned solutions."  NONPROFIT HEALTH SYSTEM